Evidence map›Paper›PMID 40940404›Full record

ArticleJournal of human genetics2026

Whole exome sequencing in Japanese spinocerebellar ataxia identifies novel variants.

Tomoaki Watanabe, Kodai Kume, Ken Inoue, Masataka Nakamura, Shinji Yamamoto, Takashi Kurashige, Tomohiko Ohshita, Taku Tazuma, Misako Kaido, Yuta Maetani and 2 more

Abstract read
In one paragraph

Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tomoaki WatanabeDepartment of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-1364-7239
Kodai KumeDepartment of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan. kumek@hiroshima-u.ac.jp.ORCID http://orcid.org/0000-0001-9266-2543
Ken InoueInoue Neurology Clinic, Hiroshima, Japan.
Masataka NakamuraDepartment of Neurology, Kansai Medical University, Osaka, Japan.
Shinji YamamotoDepartment of Neurology, Hyogo Prefectural Rehabilitation Hospital, Nishi-harima, Tatsuno, Japan.
Takashi KurashigeDepartment of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-5206-5979
Tomohiko OhshitaDepartment of Neurology, NHO Kure Medical Center, and Chugoku Cancer Center, Kure, Japan.
Taku TazumaDepartment of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Misako KaidoDepartment of Neurology, Sakai City Medical Center, Osaka, Japan.
Yuta MaetaniDepartment of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
Hirofumi MaruyamaDepartment of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0001-7613-8717
Hideshi KawakamiDepartment of Molecular Epidemiology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.ORCID http://orcid.org/0000-0002-1405-0901

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinocerebellar degeneration (SCD) is a clinically and genetically diverse group, and the dominant form of SCD (AD-SCD) is generally referred to as spinocerebellar ataxia (SCA) that primarily affects the cerebellum. Some patients do not have a definitive genetic diagnosis but may carry unknown variants of known causative genes. Here, we screened for known SCA-associated genes in patients with suspected SCA. We examined 174 patients with SCA lacking abnormal repeat expansion of known causative genes. Whole-exome sequencing (WES) was performed to screen for variants in SCA-associated genes. The identified variants were confirmed by Sanger sequencing, and their pathogenicity was determined using five web-based algorithms. WES revealed novel single-nucleotide variants (SNVs) in three genes, ELOVL4, ELOVL5, and GRM1. Patients presented with symptoms other than cerebellar symptoms. One patient with an ELOVL4 variant exhibited skin changes, a typical symptom of ELOVL4 SCA, whereas the other ELOVL4 SCA patient had no skin changes and exhibited mild parkinsonism and calcification in the globus pallidus and dentate nucleus. The patient with an ELOVL5 variant exhibited bladder and rectal disturbances. Finally, patients with GRM1 variants showed few common features beyond the cerebellar symptoms. One patient showed white matter lesions, cognitive decline, and no-no head tremors, whereas the other showed spasticity. The identification of novel SNVs in these known SCA-associated genes will expand our understanding of the genetic landscape of SCA and facilitate the diagnosis of previously undiagnosed patients.

Indexed as

Exome SequencingMembrane ProteinsSpinocerebellar AtaxiasAdultAgedEast Asian PeopleEye ProteinsFatty Acid ElongasesFemaleHumansJapanMaleMiddle AgedPolymorphism, Single NucleotideReceptors, Metabotropic GlutamateELOVL4 protein, humanELOVL5 protein, humanEye ProteinsFatty Acid ElongasesMembrane Proteinsmetabotropic glutamate receptor type 1Receptors, Metabotropic Glutamate

Identifiers

PMID40940404
PMCPMC12689424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.